{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:39:29Z","timestamp":1793911169044,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22205151"],"award-info":[{"award-number":["22205151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201148"],"award-info":[{"award-number":["32201148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172094"],"award-info":[{"award-number":["82172094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20190223"],"award-info":[{"award-number":["BX20190223"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2021JDJQ0037"],"award-info":[{"award-number":["2021JDJQ0037"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Efficient cancer immunotherapy depends on selective targeting of high bioactivity therapeutic agents to the tumours. However, delivering exogenous medication might prove difficult in clinical practice. Here we report a cooperative Nano-CRISPR scaffold (Nano-CD) that utilizes a specific sgRNA, selected from a functional screen for triggering endogenous GDSME expression, while releasing cisplatin to initiate immunologic cell death. Mechanistically, cascade-amplification of the antitumor immune response is prompted by the adjuvantic properties of the lytic intracellular content and enhanced by the heightened GDSME expression, resulting in pyroptosis and the release of tumor associated antigens. Neither of the single components provide efficient tumour control, while tumor growth is efficiently inhibited in primary and recurrent melanomas due to the combinatorial effect of cisplatin and self-supplied GSDME. Moreover, Nano-CD in combination with checkpoint blockade creates durable immune memory and strong systemic anti-tumor immune response, leading to disease relapse prevention, lung metastasis inhibition and increased survival in mouse melanomas. Taken together, our therapeutic approach utilizes CRISPR-technology to enable cell-intrinsic protein expression for immunotherapy, using GDSME as prototypic immune modulator. This nanoplatform thus can be applied to modulate further immunological processes for therapeutic benefit.<\/jats:p>","DOI":"10.1038\/s41467-023-36550-9","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T03:02:51Z","timestamp":1676084571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-2336","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-5720","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-3523","authenticated-orcid":false,"given":"Yingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-3026","authenticated-orcid":false,"given":"Dongxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-7084","authenticated-orcid":false,"given":"Xinyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-1062","authenticated-orcid":false,"given":"Xiaorong","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4438-4539","authenticated-orcid":false,"given":"Xiye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-9529","authenticated-orcid":false,"given":"Qinjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-0891","authenticated-orcid":false,"given":"Changyang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"36550_CR1","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1021\/acsnano.1c00476","volume":"15","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Protein-based nanomedicine for therapeutic benefits of cancer. ACS Nano 15, 8001\u20138038 (2021).","journal-title":"ACS Nano"},{"key":"36550_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nbt.3040","volume":"32","author":"G Walsh","year":"2014","unstructured":"Walsh, G. Biopharmaceutical benchmarks 2014. Nat. Biotechnol. 32, 992\u20131000 (2014).","journal-title":"Nat. Biotechnol."},{"key":"36550_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","volume":"359","author":"U Sahin","year":"2018","unstructured":"Sahin, U. & Tureci, O. Personalized vaccines for cancer immunotherapy. Science 359, 1355\u20131360 (2018).","journal-title":"Science"},{"key":"36550_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins, F. et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat. Rev. Clin. Oncol. 16, 563\u2013580 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36550_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"36550_CR6","doi-asserted-by":"publisher","first-page":"1606628","DOI":"10.1002\/adma.201606628","volume":"29","author":"Q Sun","year":"2017","unstructured":"Sun, Q., Zhou, Z., Qiu, N. & Shen, Y. Rational design of cancer nanomedicine: nanoproperty integration and synchronization. Adv. Mater. 29, 1606628 (2017).","journal-title":"Adv. Mater."},{"key":"36550_CR7","doi-asserted-by":"publisher","first-page":"2004940","DOI":"10.1002\/adfm.202004940","volume":"30","author":"N Wang","year":"2020","unstructured":"Wang, N. et al. Multistage sensitive NanoCRISPR enable efficient intracellular disruption of immune checkpoints for robust innate and adaptive immune coactivation. Adv. Funct. Mater. 30, 2004940 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"36550_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541\u2013555 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"36550_CR9","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.3390\/ijms22179181","volume":"22","author":"M de la Fuente","year":"2021","unstructured":"de la Fuente, M. et al. Enzyme therapy: current challenges and future perspectives. Int. J. Mol. Sci. 22, 9181 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"36550_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","volume":"30","author":"M Werle","year":"2006","unstructured":"Werle, M. & Bernkop-Schnurch, A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30, 351\u2013367 (2006).","journal-title":"Amino Acids"},{"key":"36550_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","volume":"21","author":"D Briukhovetska","year":"2021","unstructured":"Briukhovetska, D. et al. Interleukins in cancer: from biology to therapy. Nat. Rev. Cancer 21, 481\u2013499 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"36550_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","volume":"4","author":"A Mansurov","year":"2020","unstructured":"Mansurov, A. et al. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nat. Biomed. Eng. 4, 531\u2013543 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"36550_CR13","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41551-021-00797-8","volume":"5","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells. Nat. Biomed. Eng. 5, 1288\u20131305 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"36550_CR14","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/acs.nanolett.6b04955","volume":"17","author":"H Chang","year":"2017","unstructured":"Chang, H. et al. Rational design of a polymer with robust efficacy for intracellular protein and peptide delivery. Nano Lett. 17, 1678\u20131684 (2017).","journal-title":"Nano Lett."},{"key":"36550_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","volume":"15","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nat. Nanotechnol. 15, 1043\u20131052 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"36550_CR16","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1002\/anie.201914970","volume":"59","author":"L Ren","year":"2020","unstructured":"Ren, L., Lv, J., Wang, H. & Cheng, Y. A coordinative dendrimer achieves excellent efficiency in cytosolic protein and peptide delivery. Angew. Chem. Int. Ed. Engl. 59, 4711\u20134719 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"36550_CR17","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/thno.34412","volume":"9","author":"YW Lee","year":"2019","unstructured":"Lee, Y. W. et al. Protein delivery into the cell cytosol using non-viral nanocarriers. Theranostics 9, 3280\u20133292 (2019).","journal-title":"Theranostics"},{"key":"36550_CR18","doi-asserted-by":"publisher","first-page":"2110560","DOI":"10.1002\/adma.202110560","volume":"34","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. Endocytosis-independent and cancer-selective cytosolic protein delivery via reversible tagging with LAT1 substrate. Adv. Mater. 34, 2110560 (2022).","journal-title":"Adv. Mater."},{"key":"36550_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","volume":"5","author":"TD Brown","year":"2019","unstructured":"Brown, T. D., Whitehead, K. A. & Mitragotri, S. Materials for oral delivery of proteins and peptides. Nat. Rev. Mater. 5, 127\u2013148 (2019).","journal-title":"Nat. Rev. Mater."},{"key":"36550_CR20","doi-asserted-by":"publisher","first-page":"9833","DOI":"10.7150\/thno.62449","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer. Theranostics 11, 9833\u20139846 (2021).","journal-title":"Theranostics"},{"key":"36550_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.aau0629","volume":"363","author":"N Matharu","year":"2019","unstructured":"Matharu, N. et al. CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency. Science 363, 1\u201330 (2019).","journal-title":"Science"},{"key":"36550_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719\u2013724 (2009).","journal-title":"Nature"},{"key":"36550_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli, A. O. et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat. Genet. 50, 1381\u20131387 (2018).","journal-title":"Nat. Genet."},{"key":"36550_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia, L., Keel, E. & Eng, C. The clinical spectrum of PTEN mutations. Annu. Rev. Med. 71, 103\u2013116 (2020).","journal-title":"Annu. Rev. Med."},{"key":"36550_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","volume":"6","author":"SB Baylin","year":"2006","unstructured":"Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107\u2013116 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"36550_CR26","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1021\/acs.nanolett.9b03245","volume":"19","author":"JX Fan","year":"2019","unstructured":"Fan, J. X. et al. Epigenetics-based tumor cells pyroptosis for enhancing the immunological effect of chemotherapeutic nanocarriers. Nano Lett. 19, 8049\u20138058 (2019).","journal-title":"Nano Lett."},{"key":"36550_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmeth.3312","volume":"12","author":"A Chavez","year":"2015","unstructured":"Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326\u2013328 (2015).","journal-title":"Nat. Methods"},{"key":"36550_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2020.04.010","volume":"168","author":"X Song","year":"2021","unstructured":"Song, X. et al. Delivery of CRISPR\/Cas systems for cancer gene therapy and immunotherapy. Adv. Drug Deliv. Rev. 168, 158\u2013180 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"36550_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nbt.3199","volume":"33","author":"IB Hilton","year":"2015","unstructured":"Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510\u2013517 (2015).","journal-title":"Nat. Biotechnol."},{"key":"36550_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"36550_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415\u2013420 (2020).","journal-title":"Nature"},{"key":"36550_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1441-4","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis. 10, 193 (2019).","journal-title":"Cell Death Dis."},{"key":"36550_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Qi, L., Li, L. & Li, Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 6, 112 (2020).","journal-title":"Cell Death Discov."},{"key":"36550_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13277-012-0513-1","volume":"34","author":"OJ Stoetzer","year":"2013","unstructured":"Stoetzer, O. J. et al. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy. Tumour Biol. 34, 81\u201390 (2013).","journal-title":"Tumour Biol."},{"key":"36550_CR35","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Immunogenic cell death in cancer therapy: Present and emerging inducers. J. Cell Mol. Med. 23, 4854\u20134865 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"36550_CR36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.2174\/1389557517666170228115801","volume":"17","author":"A Bolhassani","year":"2017","unstructured":"Bolhassani, A., Talebi, S. & Anvar, A. Endogenous and exogenous natural adjuvants for vaccine development. Mini Rev. Med. Chem. 17, 1442\u20131456 (2017).","journal-title":"Mini Rev. Med. Chem."},{"key":"36550_CR37","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1002\/anie.202010281","volume":"60","author":"D Wu","year":"2021","unstructured":"Wu, D., Wang, S., Yu, G. & Chen, X. Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew. Chem. Int. Ed. Engl. 60, 8018\u20138034 (2021).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"36550_CR38","doi-asserted-by":"publisher","first-page":"1907267","DOI":"10.1002\/adma.201907267","volume":"32","author":"E Ploetz","year":"2020","unstructured":"Ploetz, E. et al. Metal-organic framework nanoparticles induce pyroptosis in cells controlled by the extracellular pH. Adv. Mater. 32, 1907267 (2020).","journal-title":"Adv. Mater."},{"key":"36550_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka, K. & Banchereau, J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265\u2013277 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"36550_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153\u2013167 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"36550_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan, Z. & Luo, Y. Targeting macrophages in cancer immunotherapy. Signal Transduct. Target Ther. 6, 127 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"36550_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi, Y., Shitara, K. & Nishikawa, H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat. Rev. Clin. Oncol. 16, 356\u2013371 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36550_CR43","doi-asserted-by":"publisher","first-page":"eaba4024","DOI":"10.1126\/sciadv.aba4024","volume":"6","author":"L Fang","year":"2020","unstructured":"Fang, L. et al. Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed. Sci. Adv. 6, eaba4024 (2020).","journal-title":"Sci. Adv."},{"key":"36550_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target Ther. 5, 28 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"36550_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"36550_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"36550_CR47","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1021\/acs.biomac.7b00803","volume":"18","author":"B Shi","year":"2017","unstructured":"Shi, B. et al. Challenges in DNA delivery and recent advances in multifunctional polymeric DNA delivery systems. Biomacromolecules 18, 2231\u20132246 (2017).","journal-title":"Biomacromolecules"},{"key":"36550_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80\u201386 (2010).","journal-title":"Mol. Ther."},{"key":"36550_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.omtn.2016.11.004","volume":"6","author":"A Perrin","year":"2017","unstructured":"Perrin, A., Rousseau, J. & Tremblay, J. P. Increased expression of Laminin Subunit Alpha 1 chain by dCas9-VP160. Mol. Ther. Nucleic Acids 6, 68\u201379 (2017).","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36550-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T08:08:39Z","timestamp":1676275719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36550"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36550-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"779"}}